Cleared Traditional

K820194 - CARDIAC CATHERIZATION LAB MICROPROCESS

K820194 is an FDA 510(k) clearance for CARDIAC CATHERIZATION LAB MICROPROCESS, manufactured by Compu-Cath Corp.. The device is a Class 2 Cardiovascular device with product code DXG cleared through the Traditional 510(k) pathway after a 120-day FDA review.

K820194 · Compu-Cath Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1982
Decision
120d
Days
Class 2
Risk

K820194 is an FDA 510(k) clearance for the CARDIAC CATHERIZATION LAB MICROPROCESS. Classified as Computer, Diagnostic, Pre-programmed, Single-function (product code DXG), Class II - Special Controls.

Submitted by Compu-Cath Corp. (Mchenry, US). The FDA issued a Cleared decision on May 25, 1982 after a review of 120 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1435 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Compu-Cath Corp. devices

FDA 510(k) Submission Details - K820194

510(k) Number K820194 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 25, 1982
Decision Date May 25, 1982
Days to Decision 120 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
5d faster than avg
Panel avg: 125d · This submission: 120d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXG Device Classification - Class 2, Special Controls

Product Code DXG Computer, Diagnostic, Pre-programmed, Single-function
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1435
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXG Computer, Diagnostic, Pre-programmed, Single-function

All 117
Devices cleared under the same product code (DXG) and FDA review panel - the closest regulatory comparables to K820194.
AUTOECHO
K822903 · Oxford Medilog, Inc. · Nov 1982
IL 801 THERMALDILUTION CARDIAC OUTPUT
K822972 · Instrumentation Laboratory CO · Nov 1982
MODEL 78554A DATA MGMT. PLUG-IN MODULE
K822877 · Hewlett-Packard Co. · Oct 1982
CARDIO REVUE CENTER
K820820 · Diasonics, Inc. · Apr 1982
VASCULAB SPECTRUM ANALYZER #SP25
K820898 · Medasonics, Inc. · Apr 1982
MODEL 4200 ELLESTAD STRESS TEST ANALYZER
K813222 · Del Mar Avionics · Dec 1981